Edition:
United States

Voyager Therapeutics Inc (VYGR.OQ)

VYGR.OQ on NASDAQ Stock Exchange Global Select Market

9.63USD
18 Dec 2018
Change (% chg)

-- (--)
Prev Close
$9.63
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
113,995
52-wk High
$31.91
52-wk Low
$8.99

Chart for

About

Voyager Therapeutics, Inc. is a clinical-stage gene therapy company. The Company focuses on developing treatments for patients suffering from severe diseases of the central nervous system (CNS). The Company's pipeline consists of programs for CNS indications, including advanced Parkinson's disease; a monogenic form of amyotrophi... (more)

Overall

Beta: --
Market Cap(Mil.): $557.18
Shares Outstanding(Mil.): 26.90
Dividend: --
Yield (%): --

Financials

  VYGR.OQ Industry Sector
P/E (TTM): -- 69.72 34.40
EPS (TTM): -2.30 -- --
ROI: -35.17 9.00 14.96
ROE: -45.36 10.14 16.53

Earnings vs. Estimates